Insider holders · CIK 0002056611
Latigo Biotherapeutics, Inc. · LTGO
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Foresite Capital Management VI LLC10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| Foresite Capital Fund VI LP10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| Foresite Capital Opportunity Management V, LLC10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| Foresite Capital Management V, LLC10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| Foresite Capital Opportunity Fund V, L.P.10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| Foresite Capital Fund V, L.P.10% Owner | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:21 pm EDT | Form 4 |
| James B. TananbaumDirector | — | 3,414,544 | 3,414,544 | Aug 10, 2026 · 8:00 pm EDT | Form 4 |
| 5AM Opportunities II (GP), LLC10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| 5AM Opportunities II, L.P.10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| 5AM Partners VI, LLC10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| 5AM Ventures VI, L.P.10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| Kush Parmar10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| Andrew J. Schwab10% Owner | — | 2,350,419 | 2,350,419 | Aug 12, 2026 · 4:13 pm EDT | Form 4 |
| Westlake BioPartners GP I, LLC10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Westlake BioPartners GP II, LLC10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Westlake BioPartners Fund II, L.P.10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Westlake BioPartners Opportunity Fund I, L.P.10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Westlake BioPartners Opportunity GP I, LLC10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Westlake BioPartners Fund I, L.P.10% Owner | — | 2,094,813 | 2,094,813 | Aug 11, 2026 · 6:00 am EDT | Form 4 |
| Beth C SeidenbergDirector | — | 2,094,813 | 2,094,813 | Aug 10, 2026 · 8:00 pm EDT | Form 4 |
| Sanofi10% Owner | — | 672,788 | 672,788 | Aug 12, 2026 · 8:18 am EDT | Form 4 |
| Nima FarzanPresident and CEO | — | 114,453 | 114,453 | Aug 6, 2026 · 8:31 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.